Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146.
about
Perspectives on pharmacogenomics of antiretroviral medications and HIV-associated comorbiditiesInteraction between Darunavir and Etravirine Is Partly Mediated by CYP3A5 PolymorphismGenomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202.Pharmacogenetics of drug-metabolizing enzymes in US Hispanics.Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs.
P2860
Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Discordant associations betwee ...... ical trials group study A5146.
@ast
Discordant associations betwee ...... ical trials group study A5146.
@en
type
label
Discordant associations betwee ...... ical trials group study A5146.
@ast
Discordant associations betwee ...... ical trials group study A5146.
@en
prefLabel
Discordant associations betwee ...... ical trials group study A5146.
@ast
Discordant associations betwee ...... ical trials group study A5146.
@en
P2093
P2860
P1476
Discordant associations betwee ...... ical trials group study A5146.
@en
P2093
Camlin Tierney
Carrie Dykes
David W Haas
Gene Morse
Hongyu Jiang
Lisa M Demeter
Mary Albrecht
Robin DiFrancesco
Xinyan Zhang
P2860
P304
P356
10.1097/FTD.0B013E318280D0AD
P577
2013-04-01T00:00:00Z